Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amitriptyline | The risk or severity of gastrointestinal bleeding can be increased when Amitriptyline is combined with Flunoxaprofen. |
| Protriptyline | The risk or severity of gastrointestinal bleeding can be increased when Protriptyline is combined with Flunoxaprofen. |
| Imipramine | The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Flunoxaprofen. |
| Nortriptyline | The risk or severity of gastrointestinal bleeding can be increased when Nortriptyline is combined with Flunoxaprofen. |
| Amoxapine | The risk or severity of gastrointestinal bleeding can be increased when Amoxapine is combined with Flunoxaprofen. |
| Trimipramine | The risk or severity of gastrointestinal bleeding can be increased when Trimipramine is combined with Flunoxaprofen. |
| Doxepin | The risk or severity of gastrointestinal bleeding can be increased when Doxepin is combined with Flunoxaprofen. |
| Desipramine | The risk or severity of gastrointestinal bleeding can be increased when Desipramine is combined with Flunoxaprofen. |
| Clomipramine | The risk or severity of gastrointestinal bleeding can be increased when Clomipramine is combined with Flunoxaprofen. |
| Amineptine | The risk or severity of gastrointestinal bleeding can be increased when Amineptine is combined with Flunoxaprofen. |
| Dimetacrine | The risk or severity of gastrointestinal bleeding can be increased when Dimetacrine is combined with Flunoxaprofen. |
| Butriptyline | The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Flunoxaprofen. |
| Dosulepin | The risk or severity of gastrointestinal bleeding can be increased when Dosulepin is combined with Flunoxaprofen. |
| Tianeptine | The risk or severity of gastrointestinal bleeding can be increased when Tianeptine is combined with Flunoxaprofen. |
| Oxaprotiline | The risk or severity of gastrointestinal bleeding can be increased when Oxaprotiline is combined with Flunoxaprofen. |
| Opipramol | The risk or severity of gastrointestinal bleeding can be increased when Opipramol is combined with Flunoxaprofen. |
| Amitriptylinoxide | The risk or severity of gastrointestinal bleeding can be increased when Amitriptylinoxide is combined with Flunoxaprofen. |
| Dibenzepin | The risk or severity of gastrointestinal bleeding can be increased when Dibenzepin is combined with Flunoxaprofen. |
| Quinupramine | The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Flunoxaprofen. |
| Melitracen | The risk or severity of gastrointestinal bleeding can be increased when Melitracen is combined with Flunoxaprofen. |
| Lofepramine | The risk or severity of gastrointestinal bleeding can be increased when Lofepramine is combined with Flunoxaprofen. |
| Iprindole | The risk or severity of gastrointestinal bleeding can be increased when Iprindole is combined with Flunoxaprofen. |
| Imipramine oxide | The risk or severity of gastrointestinal bleeding can be increased when Imipramine oxide is combined with Flunoxaprofen. |
| Estetrol | The risk or severity of hyperkalemia can be increased when Flunoxaprofen is combined with Estetrol. |
| Voriconazole | The serum concentration of Flunoxaprofen can be increased when it is combined with Voriconazole. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Flunoxaprofen. |
| Spironolactone | The risk or severity of hyperkalemia can be increased when Flunoxaprofen is combined with Spironolactone. |
| Capecitabine | Capecitabine may increase the nephrotoxic activities of Flunoxaprofen. |
| Olsalazine | The risk or severity of nephrotoxicity can be increased when Flunoxaprofen is combined with Olsalazine. |
| Sparsentan | The risk or severity of adverse effects can be increased when Flunoxaprofen is combined with Sparsentan. |
| Tretinoin | The risk or severity of elevated intracranial pressure can be increased when Flunoxaprofen is combined with Tretinoin. |
| Oxaliplatin | The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Flunoxaprofen. |
| Inotersen | The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Flunoxaprofen. |